Who has invested in Asieris Pharmaceuticals?

Qiming Venture Partners are named among the investors backing Asieris Pharmaceuticals.

Asieris Pharmaceuticals Funding: $106M Raised, Series D

Asieris Pharmaceuticals funding overview

Asieris Pharmaceuticals is based in Chadds Ford. Asieris Pharmaceuticals has raised $106M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in January 2020. The round record for Asieris Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Qiming Venture Partners.

Asieris Pharmaceuticals at a glance

Total raised: $106M
Latest round: Series D
Latest round date: January 2020
Headquarters: Chadds Ford
Notable investors: Qiming Venture Partners

Frequently asked about Asieris Pharmaceuticals funding

How much has Asieris Pharmaceuticals raised?: Asieris Pharmaceuticals has raised $106M in total disclosed funding across the rounds on record.
Who has invested in Asieris Pharmaceuticals?: Qiming Venture Partners are named among the investors backing Asieris Pharmaceuticals.
What was the latest Asieris Pharmaceuticals funding round?: The most recent disclosed round is a Series D, announced in January 2020.
Where is Asieris Pharmaceuticals based?: Asieris Pharmaceuticals is based in Chadds Ford.
When did Asieris Pharmaceuticals last raise?: The last disclosed Asieris Pharmaceuticals round closed in January 2020 at Series D.

Every Asieris Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Chadds Ford at a similar stage.

Asieris Pharmaceuticals Funding: $106M Raised, Series D

Asieris Pharmaceuticals funding overview

Asieris Pharmaceuticals at a glance

Frequently asked about Asieris Pharmaceuticals funding

Companies related to Asieris Pharmaceuticals (19)

Browse related funding lists (4)